ResearcherOkayama UniversityNo recent work listed

Takeshi Koujima

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5042510270. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2020: 1 paper

Papers 1

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. Co-author DOI 10.1016/j.omto.2020.03.016 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ryohei Shoji · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗
Hiroyuki Araki · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗
Shinji Kuroda · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗
Yuzo Umeda · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗
Ryuichi Yoshida · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗
Toshiyoshi Fujiwara · 1 shared paper, 2020 · strength 0.10
- Paper Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer. DOI 10.1016/j.omto.2020.03.016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.